EAU Guidelines. Edition presented at the EAU Annual Congress Amsterdam 2022 (EAU Guidelines Office, 2022).

Bamias, A. et al. Definition and diagnosis of oligometastatic bladder cancer: a delphi consensus study endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty. Eur. Urol. https://doi.org/10.1016/j.eururo.2023.05.005 (2023).

Article  PubMed  Google Scholar 

Voskuilen, C. S. et al. Staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography changes treatment recommendation in invasive bladder cancer. Eur. Urol. Oncol. https://doi.org/10.1016/j.euo.2021.01.005 (2022).

Article  PubMed  Google Scholar 

Mertens, L. S. & Horenblas, S. Bladder cancer: oligometastases and imaging. Nat. Rev. Urol. 14, 513–514 (2017).

Article  PubMed  Google Scholar 

Bajorin, D. F. et al. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma. N. Engl. J. Med. 384, 2102–2114 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powles, T. et al. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N. Engl. J. Med. 383, 1218–1230 (2020).

Article  CAS  PubMed  Google Scholar 

Heck, M. et al. Abstract LB07: long-term results from the randomized trial LEA: extended versus standard lymph node dissection in bladder cancer patients undergoing radical cystectomy. Presented at EAU23 (2023).

Lerner, S. P. et al. SWOG S1011: a phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer. J. Clin. Oncol. 41 (Suppl. 16), 4508 (2023).

Article  Google Scholar 

Zlotta, A. R. et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet. Oncol. 24, 669–681 (2023).

Article  PubMed  Google Scholar 

Spaas, M. et al. Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors: the CHEERS phase 2 randomized clinical trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2023.2132 (2023).

Article  PubMed  Google Scholar